ASPIRE Awards support cancer researchers pursuing high-risk feasibility and proof-of-concept studies to address challenging questions and advance innovative ideas from basic science to early clinical research.
ASPIRE Award: TBXT and Beyond: Expanding the Chordoma Surfaceome supports researchers studying TBXT and other tumor-specific surface targets to enable surface-targeted therapies for chordoma.
Accelerator Awards support investigators pursuing ambitious four-year neuroendocrine cancer research to advance early detection, develop new therapies, and match treatments to individual tumor biology.
The Mark Foundation Endeavor Awards support multidisciplinary teams conducting innovative collaborative research to advance cancer prevention, diagnosis, and treatment.
Advanced Clinical Research Award supports independent mid-career physicians pursuing original breast cancer clinical or human-subjects translational research to address patient needs and potential benefit.
Impact Grant - Chordoma Foundation supports researchers pursuing preclinical and translational chordoma immunology projects to explore new immunotherapy approaches and accelerate research in this disease.